Sofinnova Investments, Inc. - Q4 2022 holdings

$1.69 Billion is the total value of Sofinnova Investments, Inc.'s 53 reported holdings in Q4 2022. The portfolio turnover from Q3 2022 to Q4 2022 was - .

 Value Shares↓ Weighting
HZNP NewHorizon Therapeutics PLC$47,019,087413,173
+100.0%
2.79%
VRTX NewVertex Pharmaceuticals Inc$45,335,283156,989
+100.0%
2.69%
ALNY NewAlnylam Pharmaceuticals Inccall$23,765,000100,000
+100.0%
1.41%
ALGN NewAlign Technology Inc$17,525,79083,100
+100.0%
1.04%
ALNY NewAlnylam Pharmaceuticals Inc$13,414,86756,448
+100.0%
0.80%
KURA NewKura Oncology Inc$7,366,092593,561
+100.0%
0.44%
CYTK NewCytokinetics Inccall$4,582,000100,000
+100.0%
0.27%
AGEN NewAgenus Inccall$3,040,8001,267,000
+100.0%
0.18%
CTIC NewCTI Biopharma Corpcall$2,464,100410,000
+100.0%
0.15%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2023-02-14
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
Natera, Inc.23Q3 202320.5%
Ascendis Pharma A/S23Q3 202327.9%
NuCana plc23Q3 202315.2%
Synlogic Inc. (fmrly Mirna)22Q2 20230.9%
Y-mAbs Therapeutics, Inc.21Q3 20236.5%
ObsEva SA20Q4 202211.0%
Nucana PLC19Q3 20239.7%
SYNDAX PHARMACEUTICALS INC19Q3 20232.2%
PDS Biotechnology Corporation19Q3 20230.1%
Karuna Therapeutics, Inc.18Q3 202327.1%

View Sofinnova Investments, Inc.'s complete holdings history.

Latest significant ownerships (13-D/G)
Sofinnova Investments, Inc. Q4 2022 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
OTONOMY, INC.Sold outFebruary 14, 202200.0%

View Sofinnova Investments, Inc.'s complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-02-13
13F-HR2023-11-14
13F-HR2023-08-14
13F-HR2023-05-11
13F-HR2023-02-14
13F-HR2022-11-08
13F-HR2022-08-15
13F-HR2022-05-16
13F-HR2022-02-14
SC 13G/A2022-02-14

View Sofinnova Investments, Inc.'s complete filings history.

Compare quarters

Export Sofinnova Investments, Inc.'s holdings